Novo Nordisk's shares fell nearly 5% on Friday after results from a Phase 2a trial of the Danish drugmaker's experimental ...

Novo Nordisk said European regulators support the use of its blockbuster weight-loss drug Wegovy to help reduce heart failure ...

The European Medicines Agency backed the use of Novo Nordisk's popular drug Wegovy to help ease heart failure in people with ...

Childhood obesity rates are rising and global figures don't make for easy reading. The World Health Organization (WHO) ...

It’s a brain disease,” a prominent obesity doctor explained on a “60 Minutes” episode about the drugs. “Obesity is disease” ...

Three scientists are honored for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?

Evidence shows that blockbuster weight-loss medications can reduce obesity even in children aged 6–11, but their long-term ...

Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to ...

Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial ...

Research in people with obesity or overweight has shown that long-term exercisers have belly fat with healthier properties ...

Control of multiple risk factors "effectively nullified” the excess risk for chronic kidney disease in individuals with ...

A mechanism for metabolic disease is traced to a defective cellular scaffolding that holds together the brain’s hunger cells.